Generation Bio
(NASDAQ) GBIO
Generation Bio Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$15.27M
Net Income (TTM)
$62.63M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GBIO News
GBIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Generation Bio
Industry
Biotechnology
Sector
Health CareEmployees
115
CEO
Cameron Geoffrey McDonough, MD
Website
www.generationbio.comHeadquarters
Cambridge, MA 02142, US
GBIO Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-6%
Net Income Margin
-4%
Return on Equity
-95%
Return on Capital
-84%
Return on Assets
-51%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$19.89M
Operating Income
$142.39M
EBITDA
$74.26M
Operating Cash Flow
$88.56M
Capital Expenditure
$2.40M
Free Cash Flow
$90.96M
Cash & ST Invst.
$185.22M
Total Debt
$93.56M
Generation Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.59M
-78.9%
Gross Profit
$190.00K
-97.5%
Gross Margin
11.92%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
115
N/A
Net Income
$5.52M
+64.0%
EBITDA
$4.12M
+73.5%
Quarterly Fundamentals
Net Cash
$63.53M
-30.2%
Accounts Receivable
$391.00K
-82.3%
Inventory
$0.00
N/A
Long Term Debt
$19.74M
-76.2%
Short Term Debt
$6.35M
-41.2%
Return on Assets
-51.38%
N/A
Return on Invested Capital
-83.87%
N/A
Free Cash Flow
$52.68M
-168.3%
Operating Cash Flow
$52.68M
-169.5%